Concord Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Concord Wealth Partners's AMGN Position: Q2 2026 in Review
Concord Wealth Partners reduced its Amgen (AMGN) stake by 4.4% in Q2 2026, selling an estimated $174K and leaving 11,144 shares worth $4.04M. The position accounts for 0.46% of the portfolio, ranked #51.
Concord Wealth Partners first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.1M in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Concord Wealth Partners held 11,144 shares of Amgen worth $4.04M as of Q2 2026.
- Concord Wealth Partners sold 509 Amgen shares in Q2 2026, an estimated $174K.
- Amgen made up 0.46% of Concord Wealth Partners's portfolio in Q2 2026, its #51 holding.
- Concord Wealth Partners first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- Concord Wealth Partners's Amgen position peaked at $4.1M in Q1 2026.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.